Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
about
Amiodarone versus other pharmacological interventions for prevention of sudden cardiac deathAmiodarone versus other pharmacological interventions for prevention of sudden cardiac deathCardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theRole of risk stratification and genetics in sudden cardiac death.Late Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.Hypertrophic cardiomyopathy and sudden cardiac deathPrimary prevention of sudden cardiac death: can we afford the cost of cardioverter-defibrillators? Data from the Search-MI Registry-Italian sub-study.Patient expectations from implantable defibrillators to prevent death in heart failure.Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials.Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies.Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with thePrimary prevention of sudden cardiac death.Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysisCombined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.Cardiac arrest: the changing incidence of ventricular fibrillation.Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy.Implantable cardioverter-defibrillators: a new preventive medical option.Long-Term Prognosis in Recipients of Implantable Cardioverter-Defibrillators for Secondary Preventions in Taiwan - A Multicenter Registry Study.Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathyPatient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.Sudden cardiac death: prevalence, pathogenesis, and prevention.Prognostic Significance of Frontal QRS-T Angle in Patients with Idiopathic Dilated CardiomyopathyPrimary prevention of sudden cardiac death using implantable cardioverter defibrillators.Effect of a psychoeducational intervention on depression, anxiety, and health resource use in implantable cardioverter defibrillator patients.Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac ArrestICD's near end of life: risk versus benefit- a review.Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?Cardiovascular implantable electronic device leads in CKD and ESRD patients: review and recommendations for practice.The future of heart transplantation.PET and SPECT in heart failure.Health care utilisation after defibrillator implantation for primary prevention according to the guidelines in 2 Dutch academic medical centres.Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.
P2860
Q24187185-14E634A0-8796-417B-89D0-DF1E4350DC7DQ24240892-6467D668-F652-4284-8CFF-9EA439500B60Q26801712-5B33C3D2-B534-46F9-AF3E-B8D47A6F5C20Q28087002-3FCF033C-F8DF-49BA-8361-FAC52AE8BF7BQ30240811-FFEC44E0-9A71-48BB-8769-5C746ED0F29CQ30251600-42C37A1D-8DC7-46AD-A454-3764DF7FDE3DQ30433865-EB67B633-5930-4166-8050-EE377813B6B8Q31085557-99A5E517-14D6-4131-A2C1-4B51885C0C85Q33158361-B27154F5-9467-4227-857F-8992F09853DBQ33750390-AC46B1E2-A41D-4DA2-9DFA-2F1B7812BE93Q33812953-C5FC40CC-08EA-42D1-986E-8E959A1104CCQ34237260-5B620250-15B3-4484-AD67-FAE53448D2CDQ34384769-BE73A0A8-F4AE-41CA-9A07-5340F970AF1FQ34830023-714F34A6-9294-4F11-A7C2-478067E159F6Q35772865-DB6B617B-E6CC-4550-AA97-9287E9AB08F4Q36056217-63703BDE-061D-4219-91F8-D5BE4360F216Q36103185-F572D034-D2FE-4BE5-8388-4C1ACC20720CQ36118858-3A979275-BC38-415D-9821-00E5C7465299Q36247394-643232A7-CBCF-401C-91AC-0FF5AF7807D8Q36366306-3EC090D0-6EDC-44FF-A019-20377AF98A38Q36721259-3A250039-6F78-4836-BAA6-A589F463CB12Q36761955-93A71DA7-F790-4619-A31E-24255E7F01DBQ36859305-8EA6320D-8D85-40BA-95E6-FFF30810B88DQ36868452-25305F28-D646-4356-A85C-E21BA41E456FQ37023891-FB35DD57-6344-4931-AB9E-F776772E18A5Q37121219-DABF130E-9E4F-4B6F-B760-C03550DBF33BQ37165374-A55EFAE1-D346-4A08-9A23-FF4D31E2F270Q37185413-BBC2E99E-8085-4090-A45E-E91F624A1752Q37193184-B2BA9840-BA4A-48A6-8CA1-B77661E7A39FQ37377081-4769548D-F6AB-44CC-B44F-27BB84D98095Q37435693-800CAB60-B07D-4261-9C1E-D187A4C94D8AQ37634312-2BEADA7B-18E1-4B4D-94D7-4F39E45F97B5Q37711240-525A8911-2205-4E19-88DB-676EA0971D9CQ37973285-98517394-4D54-4B4B-89ED-731870A746B9Q37981641-CBC9AE06-3AD3-4586-9AD9-755AE2BCAA3EQ38034565-63DCD34C-9451-492D-9676-6117F81178E1Q38035388-4D912FE3-6A65-4334-AA90-F8EF62F9EA08Q38075810-1D4D153C-0DD3-47E7-A972-290BA8CF96A1Q38655221-F8FC98E0-03BD-4F2C-98E7-F6ECF3F470E4Q38659406-E2E456A7-CFE4-4C64-8F2D-C8E62FF07A65
P2860
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Implantable defibrillators for ...... randomized controlled trials.
@ast
Implantable defibrillators for ...... randomized controlled trials.
@en
type
label
Implantable defibrillators for ...... randomized controlled trials.
@ast
Implantable defibrillators for ...... randomized controlled trials.
@en
prefLabel
Implantable defibrillators for ...... randomized controlled trials.
@ast
Implantable defibrillators for ...... randomized controlled trials.
@en
P2093
P356
P1476
Implantable defibrillators for ...... randomized controlled trials.
@en
P2093
Akshay S Desai
James C Fang
Kenneth L Baughman
William H Maisel
P304
P356
10.1001/JAMA.292.23.2874
P407
P577
2004-12-01T00:00:00Z